Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1996 |
A Phase IV Study to Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis
The purpose of this study is to determine whether Gastropyloric Complex Capsules are safe and effective in the treatment of chronic atrophic gastritis (CAG).
100 Clinical Results associated with Xinjiang Biochemical Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Xinjiang Biochemical Pharmaceutical Co., Ltd.
100 Deals associated with Xinjiang Biochemical Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Xinjiang Biochemical Pharmaceutical Co., Ltd.